Change over period: —
NSE · SAMBHAAV
SAMBHAAV MED
-48.5% from the 52-week high · +11.4% above the low
Sambhaav Media Ltd. is a holding company, which engages in the provision of media services. The company is headquartered in Ahmedabad, Gujarat. The firm is engaged in the business of publishing newspapers and magazines, audio-video media in the form of the public entertainment system and digital media by way of online portals, social media and varied advertising and communication. The firm's segments include Media and Allied Business and Technology and Allied Business. Its media products include Sambhaav Metro, which is an informative afternoon daily, Abhiyaan-weekly magazine for the family; Wise TV, which is a public entertainment system; VTV News, which is a Gujarati news channel; Top FM, which consists of about eight frequency modulation (FM) radio channels in Gujarat and five FM radio channels in Jammu and Kashmir, and VTV Gujarati, which is a digital portal. The firm has launched a Web portal for news, entertainment, gaming, and knowledge sharing. The firm also launched iOS and Android-based mobile applications.
The short version. SAMBHAAV MED reported revenue of ₹11 crore for Sep 2026, up 10.0% from a year earlier. Return on equity was 0.3% in Mar 2026. Promoter holding was 62.93% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
SAMBHAAV MED trades 48.5% below its 52-week high and 11.4% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹11 cr.
0.9 pts higher than a year earlier.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11 | 10 | 13 | 11 | 10 | 9 | 11 | 11 |
| Net profit | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 1 |
| Net margin % | -2.2 | -21.1 | 3.1 | 2.8 | -3.1 | -1.8 | -0.3 | 4.5 |
| EPS (₹) | -0.01 | -0.11 | 0.02 | 0.02 | -0.02 | -0.01 | 0.0 | 0.03 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 43 | 42 | 40 | 40 | 45 | 42 | 48 | 42 |
| Net profit | 0 | 0 | 1 | -3 | 0 | -2 | 1 | 3 |
| Net margin % | 0.5 | 1.0 | 1.5 | -6.4 | 0.0 | -3.9 | 1.1 | 6.1 |
| EPS (₹) | 0.01 | 0.02 | 0.03 | -0.14 | 0.0 | -0.09 | 0.03 | 0.13 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 0.3% in Mar 2026; debt to equity is 0.01.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 0.3 | 0.5 | 0.7 | -3.1 |
| Return on capital % | 2.3 | 1.8 | 3.8 | 2.4 |
| EBITDA margin % | 14.8 | 16.4 | 20.7 | 18.6 |
| Net margin % | 0.5 | 0.9 | 1.4 | -6.1 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 1.0% | -0.3% |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Unchanged over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 62.93 | 62.93 | 62.93 | 62.93 | 62.93 | 62.93 | 62.93 | 62.93 | 0.0 |
| FII | 0.25 | 0.25 | 0.25 | 0.25 | 0.31 | 0.25 | 0.25 | 0.25 | 0.0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 36.82 | 36.82 | 36.82 | 36.82 | 36.75 | 36.82 | 36.82 | 36.82 | 0.0 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for SAMBHAAV MED are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Media stocks
Quick answers
Common questions about SAMBHAAV MED
What is the SAMBHAAV MED share price?
SAMBHAAV MED (SAMBHAAV) last closed at ₹5.46, down 3.87% on the day. Its 52-week range is ₹5.10 to ₹11.02.
What is the market cap of SAMBHAAV MED?
SAMBHAAV MED has a market capitalisation of about ₹109 crore.
How are SAMBHAAV MED's latest results?
SAMBHAAV MED reported revenue of ₹11 crore for Sep 2026, up 10.0% from a year earlier. Return on equity was 0.3% in Mar 2026. Promoter holding was 62.93% in Sep 2026, up 0.00 points over 8 quarters.
Who owns SAMBHAAV MED?
As of Sep 2026, shareholding was: Promoter 62.93%, FII 0.25%, Public 36.82%.
How many mutual funds hold SAMBHAAV MED?
0 mutual fund schemes held SAMBHAAV MED in October 2026. That compares with 0 the month before.
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.